A Concise Review of Some Clinically Relevant Interactions

Edward D. Chan,Paul T. King,Xiyuan Bai,Allen M. Schoffstall,Robert A. Sandhaus,Ashley M. Buckle

DOI: https://doi.org/10.3390/ijms25031804

IF: 5.6

2024-02-03

International Journal of Molecular Sciences

Abstract:Serine proteases are members of a large family of hydrolytic enzymes in which a particular serine residue in the active site performs an essential role as a nucleophile, which is required for their proteolytic cleavage function. The array of functions performed by serine proteases is vast and includes, among others, the following: (i) the ability to fight infections; (ii) the activation of blood coagulation or blood clot lysis systems; (iii) the activation of digestive enzymes; and (iv) reproduction. Serine protease activity is highly regulated by multiple families of protease inhibitors, known collectively as the SERine Protease INhibitor (SERPIN). The serpins use a conformational change mechanism to inhibit proteases in an irreversible way. The unusual conformational change required for serpin function provides an elegant opportunity for allosteric regulation by the binding of cofactors, of which the most well-studied is heparin. The goal of this review is to discuss some of the clinically relevant serine protease–serpin interactions that may be enhanced by heparin or other negatively charged polysaccharides. The paired serine protease–serpin in the framework of heparin that we review includes the following: thrombin–antithrombin III, plasmin–anti-plasmin, C1 esterase/kallikrein–C1 esterase inhibitor, and furin/TMPRSS2 (serine protease Transmembrane Protease 2)–alpha-1-antitrypsin, with the latter in the context of COVID-19 and prostate cancer.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper attempts to address the issue of exploring the enhancing effects of heparin and its related anionic polysaccharides on the interactions between serine proteases and serine protease inhibitors (serpins), with a particular focus on the clinical relevance of these interactions. Specifically, the paper mainly focuses on the following aspects:

1. **Interactions between serine proteases and serine protease inhibitors**: The paper provides a detailed introduction to the functions of serine proteases and their various biological roles in the body, such as anti-infection, activation of the blood coagulation system, activation of digestive enzymes, and reproduction. The activity of serine proteases is highly regulated by serine protease inhibitors (serpins), which inhibit serine proteases in an irreversible manner through a conformational change mechanism.

2. **Mechanism of action of heparin**: Heparin is a highly negatively charged polysaccharide that can enhance the inhibitory effect of serine protease inhibitors on serine proteases by inducing conformational changes in the inhibitors. The paper particularly emphasizes how heparin enhances its inhibitory effect on thrombin by binding to antithrombin III and discusses the importance of this mechanism in the anticoagulation process.

3. **Clinically relevant interaction cases**: The paper lists several specific interaction cases of clinical significance, including:
- The interaction between thrombin and antithrombin III;
- The interaction between plasmin and its inhibitors;
- The interaction between C1 esterase and C1 esterase inhibitor (C1-INH);
- The interaction between furin/TMPRSS2 and their inhibitors, particularly in the context of SARS-CoV-2 infection.

Through these studies, the paper aims to reveal how heparin and other anionic polysaccharides enhance the interactions between serine proteases and serine protease inhibitors and to explore the potential application value of these findings in disease treatment.